Virtual lecture series to delve into science of childhood cancer
The St. Jude Comprehensive Cancer Center kicks off a 15-week virtual lecture series, “The Science of Childhood Cancer,” on Aug. 13. The series will focus on key questions in pediatric cancer research, centered around themes of immunotherapy; chromatin and transcription in pediatric cancer; novel approaches to targeted molecular therapies in pediatric cancer; and pediatric cancer survivorship. The series begins with an immunotherapy seminar from Michel Sadelain, MD, PhD, of the Memorial Sloan Kettering Cancer Center, "CAR T Cells: On the Road to Synthetic Immunity."
The one-hour seminars occur Thursdays at noon Central Daylight Time (5 p.m. GMT). The invited speakers are leading experts across the spectrum of basic, translational, clinical and population science.
“In recent months, the research community has had to learn new ways of working, and virtual communication has become a vital part of how we interact and collaborate as scientists," says Charles Roberts, MD, PhD, director of the St. Jude Comprehensive Cancer Center and executive vice president. "As an NCI-designated Comprehensive Cancer Center that is focused exclusively on pediatric cancer, we want to facilitate continued advancement of research efforts in the field by engaging researchers working across the landscape of pediatric cancer to speak and stimulate ideas in high-priority areas.”
In addition to Sadelain and Roberts (August 20); speakers include Terry Fry, MD, University of Colorado Denver-Anschutz Medical Campus (August 27); Richard Kriwacki, PhD, St. Jude Department of Structural Biology (September 3); Smita Bhatia, MD, MPH, University of Alabama at Birmingham (September 10); Christine Brown, PhD, City of Hope (September 17); Kevin Krull, PhD, St. Jude Department of Epidemiology and Cancer Control, and Psychology (September 24); Iannis Aifantis, PhD, NYU Grossman School of Medicine (October 1); Paul Northcott, PhD, St. Jude Department of Developmental Neurobiology (October 8); Crystal Mackall, MD, Stanford University (October 15); Richard Young, PhD, Massachusetts Institute of Technology, and Isaac Klein, MD, PhD, Dana-Farber Cancer Institute and Whitehead Institute (October 22); Paul Thomas, PhD, St. Jude Department of Immunology (November 5); Michelle Monje, MD, PhD, Stanford University (November 12); and Eric Chow, MD, MPH, Fred Hutchinson Cancer Research Center and, Seattle Children’s Hospital and University of Washington (November 19).
Latin American hospitals implement tool to identify kids whose condition is deterioratingNov 1, 2022
CDK6: A well-known kinase commits a new ‘crime’ connecting outer radial glia to microcephalySep 27, 2022